Bloomberg Anywhere Remote Login Bloomberg Terminal Request a Demo


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last €22.92 EUR
Change Today 0.00 / 0.00%
Volume 0.0
PHIA On Other Exchanges
New York
EN Amsterdam
EN Amsterdam
As of 11:30 AM 09/4/15 All times are local (Market data is delayed by at least 15 minutes).

koninklijke philips nv (PHIA) Snapshot

Previous Close
Day High
Day Low
52 Week High
04/27/15 - €28.00
52 Week Low
10/22/14 - €20.97
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield

koninklijke philips nv (PHIA) Related Bloomberg News

View More Bloomberg News

koninklijke philips nv (PHIA) Details

Koninklijke Philips N.V. engages in healthcare, consumer lifestyle, and lighting businesses worldwide. It provides various integrated clinical solutions, including radiation oncology and portfolio management; computed tomography, magnetic resonance imaging, and molecular imaging products; digital X-ray and mammography products; interventional X-ray products in cardiology, radiology, surgery, and other areas; and ultrasound products. The company also offers enterprise patient monitoring solutions for clinical information at the patient’s bedside; patient analytics, patient monitoring, and clinical decision support systems; mother and child care products; therapeutic care products; imaging informatics for radiology and cardiology; picture archiving and communication systems and integrated electronic medical record systems; professional services; clinical support and performance, education, value-added services, installation, and remote proactive monitoring services; and care coordination, home monitoring, and care solutions. In addition, it provides mother and childcare, oral healthcare, pain management, male grooming, and beauty products; and kitchen appliances, coffee, garment care, floor care, and air purification products. Further, the company is involved in the development, manufacture, and application of various lighting products and services, including light sources and electronics, such as LED, eco-halogen, fluorescent, discharge, and incandescent light sources, as well as electronic and electromagnetic gears, modules, and drivers; functional, decorative, lifestyle, and scene-setting luminaires; and controls and luminaires for city beautification, road and sports lighting, office lighting, shop/hospitality lighting, and industry lighting. The company was formerly known as Koninklijke Philips Electronics N.V. and changed its name to Koninklijke Philips N.V. in May 2013. Koninklijke Philips N.V. was founded in 1891 and is based in Amsterdam, the Netherlands.

92,121 Employees
Last Reported Date: 07/27/15
Founded in 1891

koninklijke philips nv (PHIA) Top Compensated Officers

Chairman of the Board of Management, Chief Ex...
Total Annual Compensation: €1.5M
Chief Financial Officer, Executive Vice-Presi...
Total Annual Compensation: €869.1K
Executive Vice-President, Member of Board of ...
Total Annual Compensation: €901.9K
Compensation as of Fiscal Year 2014.

koninklijke philips nv (PHIA) Key Developments

Philips Introduces IntelliSpace Cardiovascular at ESC Congress 2015

Royal Philips announced the European debut of IntelliSpace Cardiovascular, a web-enabled image and information management system that provides sophisticated tools to access, analyze and share cardiovascular images and information anytime, from virtually anywhere. Showcased at the Philips Booth (#G200) during the ESC Congress 2015, IntelliSpace Cardiovascular marks the next generation of image and cardiology informatics solutions, serving as a nexus of interoperability that allows all care team members to access data and launch sophisticated clinical applications, like IntelliSpace Portal, or IntelliSpace ECG within a single workspace. IntelliSpace Cardiovascular enables clinicians to take a holistic view of the patients cardiovascular journey with one workspace and the ability to dive deeper into more clinical depths, said Yair Briman, Senior Vice President and General Manager of Healthcare IT for Philips. This includes accessing other third party applications, providing a comprehensive view of the patient, which helps enable care givers to deliver better patient care. Improving interoperability to enhance collaboration By centralizing patient data from different areas of the hospital, IntelliSpace Cardiovascular helps facilitate a streamlined workflow and improve patient care. The new way information is displayed allows all care team members to view the patient's history spanning diagnosis, treatment and therapy, fostering collaboration and potentially eliminating unnecessary and repetitive tests. IntelliSpace Cardiovascular can be easily incorporated into the existing infrastructure to provide clinical depth without adding complexity. Its scalable design allows clinicians to adapt the solution as their needs evolve. IntelliSpace Cardiovascular offers a suite of interoperable clinical modules designed to help improve workflow across the entire cardiovascular service line from virtually anywhere. Built-in echocardiography reporting features give cardiologists the ability to identify and eliminate inaccuracies within reports.

Philips Showcases New Integrated Cardiology Solutions to Advance Minimally Invasive Procedures

Royal Philips announced its presence at the ESC Congress 2015, where the company is showcasing its latest cardiology solutions, including Heart Model A.I. , EchoNavigator and IntelliSpace Cardiovascular, that connect people and technology with care protocols to assist diagnosis, guide treatment and enable home care. Philips newest ultrasound technology cardiac tool, HeartModel A.I., which brings automated 3D views, robust reproducibility and advanced quantification to cardiac ultrasound imaging, will make its European debut at the Philips Booth (#G200). Philips will also offer demonstrations at the booth of its advanced imaging and ultrasound solutions designed for every step of the patient journey, including: Delivering More Confident Decision-Making: HeartModel part of a suite of new tools and technologies available on Philips EPIQ Ultrasound system designed to enhance automation and reproducibility, and helps to address some of the most critical strains on overburdened hospitals and healthcare systems challenged to provide higher quality care at lower costs IntelliSpace Cardiovascular this workspace gives access to the full range of images and includes a cardiac history timeline to provide a comprehensive overview of the patients care along the health continuum Minicare 1-20 Acute A user-friendly handheld point-of-care blood testing platform that speeds up clinical diagnosis by providing results within minutes Guiding the Optimal Treatment Path EchoNavigator Fuses live 3D TEE and X-ray in real time to provide image guidance in the 3D space, supporting physicians in complex structural heart procedures to decide, guide and confirm the optimal treatment path, enabling better patient outcomes and more cost effective care AlluraClarity simplifies procedures and improves workflow, while delivering excellent image quality at a lower dose Volcano IVUS (intravascular ultrasound) - provides detailed and accurate measurements of the vessel and over a wide range of clinical studies has been shown to help ensure accurate stent expansion and apposition and a reduced need for x-ray imaging Volcano iFR Scout - pullback technology that reveals the physiologic profile of the entire vessel and is optimized to assess serial lesions and diffuse coronary disease enabling physicians to make informed treatment decisions.

Royal Philips Introduces HeartModelA.I. at ESC Congress 2015

Royal Philips announced the European debut of HeartModelA.I., a new Anatomically Intelligent Ultrasound (AIUS) tool that brings advanced quantification, automated 3D views and robust reproducibility to echocardiology. Philips' 3D AIUS ultrasound measurement method was unveiled on its EPIQ 7 ultrasound system, Philips' first ultrasound with Anatomic Intelligence capabilities, during ESC Congress 2015 in London. Using HeartModelA.I., clinicians can quickly, easily and confidently assess disease states, determine treatment, and guide related therapies. In a recent comparison at one hospital, clinicians were able to acquire and analyze the data necessary to calculate the dimensions and volumes of the left atrium and ventricle (LA and LV) between 3 and 6 times faster using 3D measurements and HeartModelA.I. than with conventional 2D measurements and conventional volume and dimensional analysis.[1] With a rich digital database of anatomical structural models and adaptive system technology, HeartModelA.I. has access to advanced clinical information that automatically adapts to variability in patient anatomy. This knowledge-based identification and patient-specific adaptation provides proven quantification of the left ventricle and atrium, and display of routine apical views. HeartModelA.I. is part of a suite of new tools and technologies available on Philips' EPIQ 7 ultrasound system. The EPIQ 7 system is designed to enhance automation and reproducibility to help address some of the most critical strains on overburdened hospitals and healthcare systems challenged to provide higher quality care at a lower cost. EPIQ 7 is known for its high-image quality, advanced automation and superb ergonomic design.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
PHIA:IM €22.92 EUR 0.00

PHIA Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Bridgestone Corp ¥3,850 JPY -56.00
Eaton Corp PLC $55.05 USD -0.24
FUJIFILM Holdings Corp ¥4,721 JPY -72.50
Linde AG €152.28 EUR -3.22
Whirlpool Corp $163.87 USD -1.47
View Industry Companies

Industry Analysis


Industry Average

Valuation PHIA Industry Range
Price/Earnings 92.5x
Price/Sales 0.9x
Price/Book 1.9x
Price/Cash Flow 53.8x
TEV/Sales 0.6x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact KONINKLIJKE PHILIPS NV, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at